Cormorant Asset Management is a venture capital, hedge fund, and investment vehicle. The firm was founded in Boston, Massachusetts, United States.
The firm is interested in asset management, finance, and financial services and offers their services in the Greater Boston Area, and New England area of the United States. The firm has made a total of seventy five investments in companies that include FORMA Therapeutics for over $100 million, and has had over forty exits. The firm has a child hub called Cormorant Asset Management Portfolio Companies.
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
Developing gene therapies to potentially cure rare diseases.
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics
Erasca creating a new generation of oncology drugs intended to not just treat, but actually cure Cancer.
Bigfoot Biomedical is a Milpitas, California-based company.
A biotechnology company developing antibody products for the treatment of infammation and severe diseases
Nested is a London-based company.
Solid Biosciences is a Cambridge, Massachusetts-based biotechnology company.
Stoke Therapeutics is a Bedford, Massachusetts-based company.
Kezar Life Sciences is a South San Francisco, California-based company.
Scholar Rock is a Cambridge, Massachusetts-based company.
Akero Therapeutics is a Cambridge, Massachusetts-based company.